Salvador Moncada, MD, PhD
Member, Scientific Advisory Board

Since 1995, Dr. Moncada has been the Director of the Wolfson Institute for Biomedical Research of the University College, London, England. Dr. Moncada received his MD from the University of El Salvador in 1970. He then earned his PhD from the Royal College of Surgeons in England where he contributed to the discovery of the mechanism of action of aspirin.

In 1975, he joined Wellcome Research Laboratories in Kent, England where he carried out further groundbreaking research, leading the team that discovered prostacyclin. This compound is still in use today for the treatment of primary pulmonary hypertension.

Dr. Moncada embarked on his third major body of work in 1986, which led to the proof that the so-called endothelial relaxing factor was the gas nitric oxide.